The functional importance for the CD32b-Smad3-mTOR pathway in renal fibrosis was further demonstrated by the ability of rapamycin to inactivate the mTOR signaling, thereby inhibiting CRP and high glucose-induced CTGF and collagen I expression. The gene discussed is FCGR2B; the disease is renal fibrosis.